Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effectiveness of a Digital Health Application for Psoriasis
Sponsor: Gaia AG
Summary
This clinical trial with 348 patients with psoriasis aims to investigate the effectiveness of a self-guided online program for patients with psoriasis. Patients will be randomized and allocated in a 1:1 ratio to either an intervention group, in which they will receive 12-month-access to an online program for psoriasis in addition to treatment as usual (TAU, n = 174), or to a control group, in which they will receive only TAU (n = 174). TAU is defined as any therapy prescribed or recommended by the GP or specialists (e.g. dermatologist, psychiatrist), which may include topical therapy, phototherapy, pharmacotherapy, psychosocial therapy, etc.
Official title: Effectiveness of a Digital Health Application for Psoriasis: Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
348
Start Date
2023-09-04
Completion Date
2026-12
Last Updated
2025-08-22
Healthy Volunteers
No
Conditions
Interventions
Online program for psoriasis (GAIA-PSO-01)
The program to-be-tested (GAIA-PSO-01) is an interactive online program for independent use by users with psoriasis. It focuses on recognized treatment elements of cognitive behavioral therapy (CBT) and behavior change techniques.
Locations (1)
GAIA AG
Hamburg, Hamburg, Germany